Aegis Therapeutics (Aegis) has signed a license agreement providing Roche access to it’s proprietary ProTek stabilisation technology. The ProTek technology covers the use of specific excipients as stabilizers
This grant is based on the successful completion of an earlier Phase I SBIR, and has as a goal the production of commercial products for clinical and research
Titan Pharmaceuticals has reported that the US Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Titan’s US patent application directed to the use of
The Chinese State Food and Drug Administration (SFDA) has approved Bayer Schering Pharma’s Betaferon (interferon beta-1b) therapy for patients with relapsing-remitting multiple sclerosis (MS). Bayer plans to launch
The Medicines Company has received European approval for the use of Angiox (bivalirudin) as an anticoagulant in patients with heart attacks (ST-segment elevation myocardial infarction (STEMI)) undergoing emergency
The Angel Fund, The ALS Therapy Alliance and Project ALS have financed a new collaboration between ALS researchers of UMMS and RXi Pharmaceuticals (Rxi). Reportedly, Robert Brown, chair
ProMetic Life Sciences (ProMetic) has entered into an agreement by ProMetic’s UK subsidiary, ProMetic Biosciences (PBL), with a multinational company looking to capture share in a growing $1billion
Max Neeman has expanded its pharmacy services facility in Delhi, India. Max Neeman Pharmacy services were initiated in 2001 and have expanded over the years serving pharmaceutical companies
Tianyin Pharmaceutical (Tianyin) has received approvals from the Chinese State Food and Drug Administration (SFDA) to produce pediatric fever and cough oral liquid in dosage form of 10ml/tube
Provectus has presented preliminary data for PH-10 Phase 2 clinical trial for psoriasis as well as for its Phase 2 clinical trial for atopic dermatitis. According to the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.